Medication-Induced Hyperlipoproteinemia

Watchlist
Retrieved
2021-01-18
Source
Trials
Genes
Drugs

Medication-induced hyperlipoproteinemia is a condition that results from the decreasing of lipoprotein lipase activity resulting in eruptive xanthomas.:535

See also

  • Normolipoproteinemic xanthomatosis
  • Cerebrotendinous xanthomatosis
  • Skin lesion